The Ticker: Tel Aviv Exchange’s IPO Wave Has Been a Loser for Investors, Survey Finds

Tel Aviv exchange’s IPO wave has been a loser for investors, Marker survey finds ■ Neon Therapeutics moves forward with $100 million U.S. IPO

TheMarker
Send in e-mailSend in e-mail
A student group exits after visiting the Tel Aviv Stock Exchange (TASE) in Tel Aviv, Israel, on Thursday, Aug. 4, 2016
A student group exits after visiting the Tel Aviv Stock Exchange (TASE) in Tel Aviv, Israel, on Thursday, Aug. 4, 2016Credit: Rina Castelnuovo/Bloomberg

Comments